Zhang Xueyan, Liu Yingbo, Deng Guangrui, Huang Bisheng, Kai Guoyin, Chen Keli, Li Juan
Key Laboratory of Ministry of Education on Traditional Chinese Medicine Resource and Compound Prescription, Key Laboratory of Resources and Chemistry of Chinese Medicine, College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China.
Department of Pharmacy, Huanggang Hospital of Traditional Chinese Medicine, Huanggang, China.
Front Pharmacol. 2021 May 17;12:676297. doi: 10.3389/fphar.2021.676297. eCollection 2021.
Activation of nucleotide oligomerization domain-like receptor protein 3 (NLRP3) inflammasome plays a crucial role in gout. has been confirmed effective for the treatment of gout in hospital preparations. Flavonoids, such as amentoflavone (AM), are the main active components of this medicine. We aimed to investigate the flavonoid extract (TF) and AM's effects on NLRP3 inflammasome and their preventive effects on gout . LC-MS method was employed to investigate the chemical profile of TF. The cellular inflammation model was established by lipopolysaccharide (LPS) or monosodium urate (MSU) stimulation. The cell membrane integrality and morphological characteristics were determined by using Lactate dehydrogenase (LDH) assay kits, propidium iodide (PI) stain, and scanning electron microscopy (SEM). The inflammatory cytokines and NLRP3 inflammasome activation were determined using enzyme-linked immunosorbent assay (ELISA), quantitative real-time polymerase chain reaction (RT-PCR), immunofluorescence staining, and western blotting. The acute gout mouse model was induced by MSU injection into footpads, and then the paw edema, inflammatory mediators, and histological examination (HE) were analyzed. The main constituents in TF are AM and robustaflavone. In the cellular inflammation model, TF down-regulated the levels of nitric oxide (NO), TNF-α, and LDH, suppressed NLRP3 inflammasome-derived interleukin-1β (IL-1β) secretion, decreased caspase-1 activation, repressed mature IL-1β expression, inhibited ASC speck formation and NLRP3 protein expression. In an acute gout mouse model, oral administration of TF to mice effectively alleviated paw edema, reduced inflammatory features, and decreased the levels of IL-1β in mouse foot tissue. Similarly, the characteristic constituent AM was also able to down-regulated the levels of NO, TNF-α, and LDH, down-regulate the mRNA expression of IL-1β, TNF-α, caspase-1, and NLRP3. Besides, the foot thickness, lymphocyte infiltration, and IL-1β level were also prevented by AM. The results indicated that TF and its main constituent AM alleviate gout arthritis via NLRP3/ASC/Caspase-1 axis suppression.
核苷酸寡聚化结构域样受体蛋白3(NLRP3)炎性小体的激活在痛风中起关键作用。已证实医院制剂对痛风治疗有效。黄酮类化合物,如穗花杉双黄酮(AM),是这种药物的主要活性成分。我们旨在研究黄酮类提取物(TF)和AM对NLRP3炎性小体的影响及其对痛风的预防作用。采用液相色谱 - 质谱联用(LC-MS)方法研究TF的化学组成。通过脂多糖(LPS)或尿酸钠(MSU)刺激建立细胞炎症模型。使用乳酸脱氢酶(LDH)检测试剂盒、碘化丙啶(PI)染色和扫描电子显微镜(SEM)测定细胞膜完整性和形态特征。使用酶联免疫吸附测定(ELISA)、定量实时聚合酶链反应(RT-PCR)免疫荧光染色和蛋白质印迹法测定炎性细胞因子和NLRP3炎性小体的激活情况。通过向足垫注射MSU诱导急性痛风小鼠模型,然后分析爪肿胀、炎性介质和组织学检查(苏木精 - 伊红染色,HE)结果。TF中的主要成分是AM和罗布斯塔黄酮。在细胞炎症模型中,TF下调一氧化氮(NO)、肿瘤坏死因子 - α(TNF-α)和LDH的水平,抑制NLRP3炎性小体衍生白介素 - 1β(IL-1β)的分泌,降低半胱天冬酶 - 1(caspase-1)的激活,抑制成熟IL-1β的表达,抑制凋亡相关斑点样蛋白(ASC)斑点形成和NLRP3蛋白表达。在急性痛风小鼠模型中,给小鼠口服TF可有效减轻爪肿胀,减少炎症特征,并降低小鼠足部组织中IL-1β的水平。同样,特征成分AM也能够下调NO、TNF-α和LDH的水平,下调IL-1β、TNF-α、caspase-1和NLRP3的mRNA表达。此外,AM还可预防足厚度、淋巴细胞浸润和IL-1β水平升高。结果表明,TF及其主要成分AM通过抑制NLRP3/ASC/caspase-1轴减轻痛风性关节炎。